402436

Aggressive fibromatosis: treatment modalities and results

Article

Last updated: 13 Jan 2025

Subjects

-

Tags

-

Abstract

Aggressive fibromatosis are rare neoplasms with unpredictable behavior and high local relapse rate following surgical resection. This, together with the lack of large randomized trials, have resulted in much debate in evaluation of alternative therapeutic intervention. We have reviewed our results of treatment of these lesions in an attempt to define guidelines of treatment and patterns of failure.
Material and Methods: We reviewed the records of 149 patients diagnosed as aggressive fibromatosis in our institute between January 1992 and January 2001. Twelve records were discarded due to incomplete data thus leaving 137 records for evaluation (89 females, 48 males; mean age 26.4 years). Patients were divided into two groups according to the treatment modality; surgery alone group and combined surgery and radiation therapy group. Evaluation included local control rates and analysis of failure as regards therapeutic modality used, margin status, and presentation status (primary or recurrent).
Results: Ninety eight patients were treated with surgery alone. The initial local control rate was 62.2% with a median time to recurrence of 25.4 months. Thirty nine patients received adjuvant radiation therapy with a local control rate of 82.1%. The difference in the local control rates between the two groups was statistically significant (p = 0.014). Margin status was the most important predictor of failure. The local recurrence rates for positive and close margins (<0.5 cm) were 50% and 40.9% respectively in the surgery alone group. Previous recurrence had a significant negative impact on patients' outcome. The local control rates for primary and recurrent cases were 75.6% and 46.8% respectively.
Conclusion: Surgical resection with wide safety margin whenever feasible is the appropriate initial therapy for these group of lesions. In case, wide margins could not be achieved and for recurrent disease, the addition of radiation therapy will improve the final outcome of these patients. 

DOI

10.21608/ejsur.2002.402436

Keywords

aggressive fibromatosis, Desmoid tumor

Authors

First Name

Sherif

Last Name

Maamoun

MiddleName

I.

Affiliation

Surgical Oncology, National Cancer Institute, Cairo University

Email

-

City

-

Orcid

-

First Name

Samy

Last Name

Shehata

MiddleName

R.

Affiliation

Surgical Oncology, National Cancer Institute, Cairo University

Email

-

City

-

Orcid

-

First Name

Tarek

Last Name

Essam

MiddleName

-

Affiliation

Surgical Oncology, National Cancer Institute, Cairo University

Email

-

City

-

Orcid

-

First Name

Manal

Last Name

El-Baradie

MiddleName

M.

Affiliation

Radiation Therapy, National Cancer Institute, Cairo University

Email

-

City

-

Orcid

-

Volume

21

Article Issue

2

Related Issue

52540

Issue Date

2002-04-01

Receive Date

2025-01-02

Publish Date

2002-04-01

Page Start

890

Page End

894

Print ISSN

1110-1121

Online ISSN

1687-7624

Link

https://ejsur.journals.ekb.eg/article_402436.html

Detail API

http://journals.ekb.eg?_action=service&article_code=402436

Order

402,436

Type

Original Article

Type Code

3,086

Publication Type

Journal

Publication Title

The Egyptian Journal of Surgery

Publication Link

https://ejsur.journals.ekb.eg/

MainTitle

Aggressive fibromatosis: treatment modalities and results

Details

Type

Article

Created At

07 Jan 2025